Publications
Filters: First Letter Of Title is C [Clear All Filters]
“Choosing where to give birth: Factors influencing migrant women's decision making in two regions of Thailand”, PLoS One, vol. 15, no. 4, p. e0230407, 2020.
, “Cohort profile: molecular signature in pregnancy (MSP): longitudinal high-frequency sampling to characterise cross-omic trajectories in pregnancy in a resource-constrained setting”, BMJ Open, vol. 10, no. 10, p. e041631, 2020.
, “Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria”, Clin Infect Dis, vol. 68, no. 8, pp. 1311-1319, 2019.
, “Community engagement, social context and coverage of mass anti-malarial administration: Comparative findings from multi-site research in the Greater Mekong sub-Region”, PLoS One, vol. 14, no. 3, p. e0214280, 2019.
, “Comparative 3D genome organization in apicomplexan parasites”, Proc Natl Acad Sci U S A, vol. 116, no. 8, pp. 3183-3192, 2019.
, “Competing risk events in antimalarial drug trials in uncomplicated Plasmodium falciparum malaria: a WorldWide Antimalarial Resistance Network individual participant data meta-analysis”, Malar J, vol. 18, no. 1, p. 225, 2019.
, “Contribution of Asymptomatic Plasmodium Infections to the Transmission of Malaria in Kayin State, Myanmar”, J Infect Dis, vol. 219, no. 9, pp. 1499-1509, 2019.
, “Contribution of Functional Antimalarial Immunity to Measures of Parasite Clearance in Therapeutic Efficacy Studies of Artemisinin Derivatives”, J Infect Dis, vol. 220, no. 7, pp. 1178-1187, 2019.
, “Challenges arising when seeking broad consent for health research data sharing: a qualitative study of perspectives in Thailand”, BMC medical ethics, vol. 19, no. 1, p. 86, 2018.
, “Challenges to primary healthcare services in the management of non-communicable diseases in marginalised populations on the Thailand–Myanmar border: a pilot survey”, Tropical doctor, p. 0049475518786853, 2018.
, “Changes in genome organization of parasite-specific gene families during the Plasmodium transmission stages”, Nature Communications, vol. 9, p. 1910, 2018.
, “Characterising blood stage antimalarial drug minimum inhibitory concentrations in vivo using reinfection patterns”, Antimicrobial agents and chemotherapy, pp. AAC. 02476-17, 2018.
, “Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria”, Clinical Infectious Diseases, 2018.
, “Comparative Heterochromatin Profiling Reveals Conserved and Unique Epigenome Signatures Linked to Adaptation and Development of Malaria Parasites”, Cell Host Microbe, vol. 23, no. 3, pp. 407-420 e8, 2018.
, “Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria”, Clin Infect Dis, vol. 67, no. 10, pp. 1543-1549, 2018.
, “A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum”, Nat Commun, vol. 9, no. 1, p. 1837, 2018.
, “The contribution of asymptomatic Plasmodium infections to the transmission of malaria in Kayin state, Myanmar”, J Infect DisJ Infect Dis, 2018.
, “Cytochemical flow analysis of intracellular G6PD and aggregate analysis of mosaic G6PD expression”, Eur J Haematol, vol. 100, no. 3, pp. 294-303, 2018.
, “Challenges to replace ACT as first-line drug”, Malar J, vol. 16, no. 1, p. 296, 2017.
, “Chloroquine-Primaquine versus Chloroquine Alone to Treat Vivax Malaria in Afghanistan: An Open Randomized Superiority Trial”, The American journal of tropical medicine and hygiene, vol. 97, no. 6, pp. 1782 - 1787, 2017.
, , “Community engagement for the rapid elimination of malaria: the case of Kayin State, Myanmar”, Wellcome Open Res, vol. 2, p. 59, 2017.
, , “Capsular typing method for Streptococcus agalactiae using whole genome sequence data”, J Clin Microbiol, 2016.
, “Comparison of the Performances of Five Primer Sets for the Detection and Quantification of Plasmodium in Anopheline Vectors by Real-Time PCR”, PLoS One, vol. 11, no. 7, p. e0159160, 2016.
, “Challenges in tackling tuberculosis on the Thai-Myanmar border: findings from a qualitative study with health professionals”, BMC Health Serv Res, vol. 15, no. 1, p. 464, 2015.
, “Climate induces seasonality in pneumococcal transmission”, Sci Rep, vol. 5, p. 11344, 2015.
, “Comparison between Flow Cytometry, Microscopy, and Lactate Dehydrogenase-Based Enzyme-Linked Immunosorbent Assay for Plasmodium falciparum Drug Susceptibility Testing under Field Conditions”, J Clin Microbiol, vol. 53, no. 10, pp. 3296-303, 2015.
, “Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention”, Sci Transl Med, vol. 6, no. 260, p. 260ra147, 2014.
, “Characterization of G6PD Genotypes and Phenotypes on the Northwestern Thailand-Myanmar Border”, PLoS ONE, vol. 9, no. 12, p. e116063, 2014.
, “Characterization of the Commercially-Available Fluorescent Chloroquine-BODIPY Conjugate, LynxTag-CQGREEN, as a Marker for Chloroquine Resistance and Uptake in a 96-Well Plate Assay”, PLoS One, vol. 9, no. 10, p. e110800, 2014.
, “Clinical audit to enhance safe practice of skilled birth attendants for the fetus with nuchal cord: evidence from a refugee and migrant cohort”, BMC Pregnancy Childbirth, vol. 14, no. 1, p. 76, 2014.
, “Complex polymorphisms in the Plasmodium falciparum Multidrug Resistance Protein 2 gene and its contribution to antimalarial response”, Antimicrob Agents Chemother, vol. 58, no. 12, pp. 7390-7397, 2014.
, “Comprehensive Identification of Single Nucleotide Polymorphisms Associated with Beta-lactam Resistance within Pneumococcal Mosaic Genes”, PLoS Genet, vol. 10, no. 8, p. e1004547, 2014.
, “Challenges and prospects for dengue and malaria control in Thailand, Southeast Asia”, Trends Parasitol, 2013.
, “Changes in the body weight of term infants, born in the tropics, during the first seven days of life”, BMC Pediatr, vol. 13, no. 1, p. 93, 2013.
, “Can we teach an old drug new tricks?”, Trends Parasitol, 2012.
, “Close kinship within multiple-genotype malaria parasite infections”, Proceedings of the Royal Society B: Biological Sciences, 2012.
, “Closing the translation gap for justice requirements in international research”, J Med Ethics, vol. 38, no. 9, pp. 552-558, 2012.
, “Comparability of tympanic and oral mercury thermometers at high ambient temperatures”, BMC Res Notes, vol. 5, no. 1, p. 356, 2012.
, “Cryopreserved Plasmodium vivax and cord blood reticulocytes can be used for invasion and short term culture”, Int J Parasitol, vol. 42, no. 2, pp. 155-60, 2012.
, “Chloroquine resistant vivax malaria in a pregnant woman on the western border of Thailand”, Malar J, vol. 10, p. 113, 2011.
, “Considerations on the use of nucleic acid-based amplification for malaria parasite detection”, Malar J, vol. 10, no. 1, p. 323, 2011.
, “Community engagement on the Thai-Burmese border: rationale, experience and lessons learnt”, International Health, vol. 2, no. 2, pp. 123-129, 2010.
, “Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria”, Eur J Clin Pharmacol, 2010.
, “Complex Interactions between soil-transmitted helminths and malaria in pregnant women on the Thai-Burmese border”, PLoS Negl Trop Dis, vol. 4, no. 11, p. e887, 2010.
, “Castor oil for induction of labour: not harmful, not helpful”, Aust N Z J Obstet Gynaecol, vol. 49, no. 5, pp. 499-503, 2009.
, “Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment”, PLoS ONE, vol. 4, no. 2, p. e4551, 2009.
, “Cost-effectiveness of artesunate for the treatment of severe malaria”, Trop Med Int Health, vol. 14, no. 3, pp. 332-7, 2009.
, “Chloroquine pharmacokinetics in pregnant and nonpregnant women with vivax malaria”, Eur J Clin Pharmacol, 2008.
, “Clinically uncomplicated Plasmodium falciparum malaria with high schizontaemia: a case report”, Malar J, vol. 7, p. 57, 2008.
, “Case management of malaria in pregnancy”, Lancet Infect Dis, vol. 7, no. 2, pp. 118-25, 2007.
, “Chloroquine prophylaxis against vivax malaria in pregnancy: a randomized, double-blind, placebo-controlled trial”, Trop Med Int Health, vol. 12, no. 2, pp. 209-18, 2007.
, “Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms”, PLoS ONE, vol. 2, no. 10, p. e1089, 2007.
, “A case control auditory evaluation of patients treated with artemether-lumefantrine”, American Journal of Tropical Medicine and Hygiene, vol. 74, no. 2, pp. 211-214, 2006.
, “Characterization of Solid Counterfeit Drug Samples by Desorption Electrospray Ionization and Direct-analysis-in-real-time Coupled to Time-of-flight Mass Spectrometry”, ChemMedChem, vol. 1, no. 7, pp. 702-705, 2006.
, “Correction: Manslaughter by Fake Artesunate in Asia‚ÄîWill Africa Be Next?”, PLoS Med, vol. 3, no. 8, p. e324, 2006.
, ,
“Central role of the spleen in malaria parasite clearance”, Journal of Infectious Diseases, vol. 185, no. 10, pp. 1538-41., 2002.
, “Combination therapy for malaria: the way forward?”, Drugs, vol. 62, no. 9, pp. 1315-29, 2002.
, “Comparison of oral artesunate and dihydroartemisinin antimalarial bioavailabilities in acute falciparum malaria”, Antimicrob Agents Chemother, vol. 46, no. 4, pp. 1125-7., 2002.
, “A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 62, no. 1, pp. 65-9, 2000.
, “Cerebral uptake of mefloquine enantiomers in fatal cerebral malaria”, International Journal of Clinical Pharmacology and Therapeutics, vol. 37, no. 1, pp. 58-61, 1999.
, “Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine”, Clin Pharmacokinet, vol. 37, no. 2, pp. 105-25., 1999.
, “Clinical features cannot predict a diagnosis of malaria or differentiate the infecting species in children living in an area of low transmission”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 1, pp. 45-9, 1998.
, “Community based studies on the treatment of multi-drug resistant falciparum malaria”, in ICOPA IX - 9th International congress of parasitology, Nakasaki, Japan, 1998, pp. 523-528.
, “Consensus recommendation on the treatment of malaria in Southeast Asia”, Southeast Asian Journal of Tropical Medicine and Public Health, vol. 29, no. 2, pp. 355-60, 1998.
, “The chromosomal organization of the Plasmodium falciparum var gene family is conserved”, Mol Biochem Parasitol, vol. 87, no. 1, pp. 49-60, 1997.
, “Comparative bioavailability of oral, rectal, and intramuscular artemether in healthy subjects: use of simultaneous measurement by high performance liquid chromatography and bioassay”, British Journal of Clinical Pharmacology, vol. 42, no. 5, pp. 599-604, 1996.
, “Clinical features and outcome of severe malaria in Gambian children”, Clinical Infectious Diseases, vol. 21, no. 3, pp. 577-87, 1995.
, “Comparison of capillary whole blood, venous whole blood, and plasma concentrations of mefloquine, halofantrine, and desbutyl-halofantrine measured by high-performance liquid chromatography”, American Journal of Tropical Medicine and Hygiene, vol. 51, no. 6, pp. 778-84, 1994.
, “Cardiac effects of antimalarial treatment with halofantrine”, Lancet, vol. 341, pp. 1054-6, 1993.
, “Comparison of artemether and chloroquine for severe malaria in Gambian children”, Lancet, vol. 339, pp. 317-21, 1992.
,